Introduction
============

Photochemical damage of biological molecules by reactive oxygen species (^1^O~2~, O~2~^-·^ , HO^·^, RO^·^ , \[O\] etc.) have received increasing attention recently \[[@B1-molecules-06-00052],[@B2-molecules-06-00052]\]. Studies indicate that a number of biological pigments e.g. hematoporphyrin, riboflavin and chlorophyll etc. can readily sensitize the photooxygenation of Δ^5^-steroids such as cholesterol, which may cause some diseases or damage to biological organs. One of the effects found was an increase the brittleness of the cell membrane, which leads to hemolysis \[[@B3-molecules-06-00052]\]. It was also verified that oxygen can affect the synthesis and metabolism of pregnenolone \[[@B4-molecules-06-00052]\]. In most cases, the sensitized photooxygenations of cholesterol and other steroids involve singlet oxygen reactions \[[@B3-molecules-06-00052],[@B4-molecules-06-00052],[@B5-molecules-06-00052]\]. However, the structure-reactivity features of steroids in these photooxygenations and their photochemical damage are still less well understood. In this work, 9,10- dicyanoanthracene (DCA) and lumiflavin (LF) are selected as new sensitizers to further study the photooxygenation products and their distributions in cholesterol derivatives **1**-**3** and pseudo-cholesterol analogs **4**-**5**, and potential influence of photochemical lesions to Δ-steroids.

Results and Discussion
======================

Riboflavin (RF) is known as a typical ^1^O~2~ sensitizer, but its light stability is not very good because of facile cleavage of the polyhydroxy-containing side chain. We found that the light stability of LF is better than its RF derivatives, hence using LF may be beneficial in the title reaction. DCA not only has high light stability, but also is frequently used as an electron transfer sensitizer for aromatic compounds \[[@B6-molecules-06-00052]\]. However, Foote \[[@B7-molecules-06-00052]\] and the authors \[[@B8-molecules-06-00052]\] demonstrated that DCA also is a good sensitizer to initiate the ^1^O~2~ reaction of alicyclic olefins and Δ-steroids. It was found in this work that in the presence of DCA or LF, **1**-**3** can undergo a facile photooxygenation in solution such as acetonitrile and pyridine to give the 6-en-5á - and 5-en-7(α,β)-hydroperoxides, **1\'a-3\'a** and **1\'b-3\'b**, respectively, with good conversions (80-90%). Since these hydroperoxides are not very stable at room temperature, they were treated with Ph~3~P and reduced to the corresponding enols **1a-3a** and **1b-3b**. The reaction is represented as follows: molecules-06-00052-f001_Scheme 1Scheme 1

The data for the (**a, b**) types of products and their distribution for the DCA- and LF-sensitized photooxygenations of **1** - **5** are listed in [Table 1](#molecules-06-00052-t001){ref-type="table"}. It can be seen from this data that the reactions of the substituted cholesterols **1**-**3** give similar products, i.e enol derivatives of types **a**- and **b**- and **1a-3a** are formed stereospecifically, whereas **1b-3b** is a mixture of 7α - and 7β-hydroxy epimers with no stereospecificity. By comparison of the conversions of **1**-**3** in [Table 1](#molecules-06-00052-t001){ref-type="table"}, it seems that DCA is more reactive than LF for sensitizinge the reaction.

The title reactions lead to the major **a-**type of enol product with an adjacent double-bond migration, which is in accord with the ene reaction of ^1^O~2~ and the reported sensitized photooxygenations of other Ä-steroids \[[@B4-molecules-06-00052]\]. Accordingly, the title reaction may follow the ^1^O~2~ pathway (see [Scheme 2](#molecules-06-00052-f002){ref-type="scheme"}). Because of axial hindrance of the 19-angular methyl group at C-10, attack at the 5α- orientation of the 5-C=C bond by ^1^O~2~, which is generated from energy transfer, is more favored, producing the peroxide intermediate. A suprafacial 7α- H shift and adjacent C=C migration lead to 5α- OOH product (**a\'**). In addition, the rearrangement of **a\' b\'**- hydroperoxide in the sensitized photooxygenations of Δ-steroids is well established to proceed through allylperoxy radicals or \[[@B2-molecules-06-00052], [@B3-molecules-06-00052]\] sigmatropic rearrangement \[[@B9-molecules-06-00052], [@B10-molecules-06-00052]\]. The results in [Table 1](#molecules-06-00052-t001){ref-type="table"} also show that the title reaction of **1** - **3** always accompanies formation of the **b-**type of enol product. The yields of **1b**-**3b** varied in the range of 12 - 80 %, depending on the conditions employed. This indicates existence of the subsequent rearrangement of **a\' b\'**- hydroperoxide.
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molecules-06-00052-t001_Table 1

###### 

Sensitized photooxygenation of **1** - **5** and their product distributions.

  --------------------------------------------------------------------------------------------
  Steroids   Sensitizer   Solvent   Reaction Time h   Conversion\   Relative yields (%)   
                                                      %                                   
  ---------- ------------ --------- ----------------- ------------- --------------------- ----
  1          LF           Py        6                 90            86                    12

  1          LF           MeCN      4                 80            20                    80

  1          DCA \*       MeCN      0.2               2             90                    10

  1          DCA          MeCN      6                 90            43                    57

  1          RB \*        MeCN      0.2               2             90                    10

  2          LF           MeCN      10                80            44                    56

  2          DCA          MeCN      8                 85            42                    58

  3          LF           MeCN      12                74            72                    28

  3          DCA          MeCN      7                 84            68                    32

  4          DCA          MeCN      5                 47            80                    20

  5          DCA          MeCN      7                 50            76                    24
  --------------------------------------------------------------------------------------------

\* cf. Ref. 7.

Pseudocholesterol is not found in living systems and, unlike cholesterol, it has no biological activity, although it possesses the same tetracyclic diterpene structural framework and functional groups (C=C, OH, CH~3~ and C~8~H~17~) as found in cholesterol. Interestingly, its 4-en-7β-ol positions are oppositely arranged as compared with 5-en-3β-ol positions in the A and B rings of cholesterol. This structural similarity may lead to a similar reaction behavior and products possessing reversed enol positions. Indeed, the results indicate that the DCA-sensitized photooxygenation of pseudocholesterols **4**, **5** in MeCN under the same conditions afforded similar **a-** and **b-**type hydroperoxides, **4\'a-5\'a** and **4\'b-5\'b**, and subsequent 4-en-7β-ol products, **4a-5a** and **4b-5b**, after treatment with Ph~3~P (see [Table 1](#molecules-06-00052-t001){ref-type="table"}). It is shown in [Scheme 3](#molecules-06-00052-f003){ref-type="scheme"} that the enol positions in theA and B rings of **4** and **5** are reversed compared to those of substituted cholesterols **1**-**3**.
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This resemblance reflects that the ene reaction of ^1^O~2~ with endocyclic C=C migration in both cases (i.e. B ring in cholesterol and A ring in pseudocholesterol, respectively) occurs in the same ring to give 5α-hydroperoxides and no exocyclic enol product was observed.

Since the photooxygenation of steroids is known to cause an increased brittleness of the cell membrane due to increased polarity of hydroxy and hydroperoxide products which leads to hemolysis \[[@B3-molecules-06-00052]\], the preliminary results in this work for modulating photooxygenation of the title steroids via the ene reaction of ^1^O~2~ may provide further understanding on their potential consequence of photochemical damage toΔ^5^-steroids.

Experimental
============

Chemicals and instruments
-------------------------

Cholestrol (**1)** was Fluka reagent grade, recrystallized from methanol, m.p.148-150 °C. 3β-Methoxy-cholest-5-ene (**2)** was prepared as follows: (1) Cholesteryl tosylate: 38.6 g of **1** was dissolved in warm pyridine (50 mL), and then toluenesulfonyl chloride (28.5 g) was added. A white precipitate appeared after 5 min. The mixture was left standing overnight and extracted with ethyl ether. Workup gave the product, m.p. 132-133 C (ref. \[[@B16-molecules-06-00052]\] 131.5-132.5 C). The yield was 48 g (88 %). (2) Preparation of 3β-methoxy-cholest-5-ene **2**: 2g of Cholesteryl tosylate were dissolved in 50 mL of methanol and refluxed for 0.5 h. A white precipitate appeared after cooling the solution. Workup gave **2**, m.p. 81-82 C. The yield of 2 was 1.6 g (90 %). ν~max~: 2945, 2868, 1667 (w, C=C), 1455, 1188, 1103, 934 cm^-1^; m/z: 400 (M^+^, 80 %), 385 (M^+^-Me), 368 (M^+^-MeOH, 100 %).

Cholesteryl acetate (**3)** was prepared according to the literature procedure \[[@B11-molecules-06-00052]\]. Pseudocholesterol (**4)** was synthesized from cholesterol via a three-step reaction according to the literature method \[[@B12-molecules-06-00052]\]. 7β-Methoxypseudo-cholesterol-4-ene (**5)** was prepared by a similar procedure for **2**. 9,10-Dicyano- anthracene (DCA) was Aldrich reagent grade, recrystallized from toluene, m.p. 324-326 C. Lumiflavin (LF) was prepared by a two-step reaction of riboflavin (RF) according to the literature method \[[@B13-molecules-06-00052]\], m.p. 350-352 C (dee.); m/e: 256 (M^+^), 242 (M^+^-14, 100 %). Acetonitrile and pyridine were prepared by standard method and other reagents were used as purchased. ^1^H-NMR spectra were recorded on a Bruker AM 400 (TMS as internal standard). MS spectra were measured on a Finigan 4021. IR spectra were obtained on a Nicolet FT-IR 5DX. UV spectra were recorded on a Shimadzu UV-240. Melting points are uncorrected.

Photooxygenations and product isolation
---------------------------------------

Photolysis was carried out in a photochemical glass reactor equipped with a water-cooled jacket attached to an automatic controller. The light source was a 500 w medium-pressure mercury lamp. The mixture of steroid, sensitizer and solvent in a glass tube was irradiated with continuous oxygen bubbling. The progress of reactions was monitored by TLC.

### (1) LF-sensitized photooxygenation of **1** in MeCN {#sec1-molecules-06-00052}

77.2 mg of **1** in MeCN solution (80 mL) containing LF (5×10^-4^ mol dm^-3^) was irradiated for 4h with oxygen bubbling, then Ph~3~P (100mg) was added and the mixture stirred for 0.5 h. The solvent was evaporated and the mixture was chromatographed on silica gel eluting with toluene/ethyl acetate. The following three purified components were obtained: 15.2 mg of recovered cholesterol (**1)**; 12 mg of cholest-6-en-3β, 5α-diol (**1a**), recrystallized from methanol, m.p. 147-148 C (ref: 147-148 C \[[@B15-molecules-06-00052]\]). ν~max~: 3600, 3423 (b, OH), 1636 (w, C=C) cm^-1^; m/e: 384 (M^+^-H~2~O, 30 %), 366 (M^+^-2H~2~O, 100%), 351, 143, 135 (100 %); δ~H~ (CDCl~3~): 0.71 (s, 3H, 18-CH~3~), 0.93 (s, 3H, 19-CH~3~), 4.13 (m, 1H, 3-CH), 5.57 (1H, dd, J=9.8, 2.5 Hz, 6-H), 5.63 (1H, dd, J=9.8, 1.7 Hz, 7-H); 47 mg of cholest-5-en-3β,7 (α,β)- diol (**1b)**, which was further separated by silica gel chromatograph to give cholest-5-en-3β,7β-diol **1b-** (α)**,**m.p. 176-178 C. ν~max~: 3368 (b, OH), 2933, 2867 (s, C-H), 1662 (w, C=C), 1467, 1382 cm^-1^; m/e: 402 (M^+^), 384 (M^+^-H~2~O), 369 (M^+^-H~2~O-CH~3~, 90 %), 351 (M^+^-2H~2~O-CH~3~), 247, 135 (100 %); δ~H~ (CDCl~3~): 0.69 (s, 3H, 18-CH~3~), 1.02 (s, 3H, 19-CH~3~), 3.60 (m, 1H, 3-CH), 3.87 (m, 1H, 7-H), 5.61 (1H, dd, J=4.8, 1.4 Hz, 6-H) and cholest-5-en-3β,7β-diol **1b-**(β), m.p. 184-186 C. ν~max~: 3376, 3363 (b, OH), 2943, 2867 (s, C-H), 1662 (w, C=C), 1466 cm^-1^; m/e: 402 (M^+^), 384 (M^+^-H~2~O, 100 %), 369 (M^+^-H~2~O-CH~3~, 40 %), 351 (M^+^-2H~2~O-CH~3~), 247, 135; δ~H~ (CDCl~3~): 0.69 (s, 3H, 18-CH~3~), 1.06 (s, 3H, 19-CH~3~), 3.58 (m, 1H, 3-CH), 3.87 (m, 1H, 7-H), 5.30 (t, 1H, 6-H).

### (2) LF-sensitized photooxygenation of **1** in pyridine

The same amount of **1**, LF and solvent as in experiment (1) was used. Irradiation of the mixture for 6 h with oxygen bubbling was carried out, then a similar work-up and isolation as in (1) were employed. The following three purified compounds were obtained: 7.2 mg of recovered **1**, 59.2 mg of **1a** and 8.4 mg of **1b**. Their spectra data were the same as those given in (1).

### (3) DCA -sensitized photooxygenation of **1** in MeCN

Compound **1** (77.2 mg ; 0.03 mmol) in DCA-MeCN solution (80 mL, 4×10^-4^ mol dm^-3^) was irradiated for 6 h with oxygen bubbling, then a similar work-up and isolation procedure as in (1) were employed. The following three purified compounds were obtained: 8 mg of recovered **1**, 30.1 mg of **1a** and 39.8 mg of **1b** were obtained. Their spectra data were the same as those described in (1).

### (4) LF-sensitized photooxygenation of **2** in MeCN {#sec4-molecules-06-00052}

Compound **2** (80 mg) in an MeCN solution containing LF (150 mL; 5×10^-4^ mol dm^-3^) was irradiated for 10 h with oxygen bubbling, then a similar work-up and isolation procedure as in (1) were used. The following three purified compounds were obtained: Recovered 3β−methoxy-cholest-5-ene (**2)** (15.8 mg), m.p. 81-83 C; 3β-methoxy-cholest-6-en-5α-ol (**2a**) (26.3 mg); ν~max~: 3430 (b, OH), 2945, 2868, 1665 (w, C=C), 1454, 1384, 1103, 1018 cm^-1^; m/e: 401 (M^+^-Me), 398 (M^+^-H~2~O, 100 %), 384 (M^+^-80%), 353, 301, 210, 71, 43; δ~H~ (CDCl~3~): 0.70 (s, 3H, 18-CH~3~), 1.19 (s, 19-CH~3~), 3.36 (s, 3H, OCH~3~), 3.70 (m, 1H, 3-CH), 5.65 (m, 2H, 6- and 7-H) and 3β-methoxy-cholest-5-en-7 (α,β)-ol (**2b)** (33.5 mg); ν~max~: 3430 (b, OH), 2938, 2868, 1665 (w, C=C), 1468, 1384, 1101 cm^-1^; m/e: 416 (M^+^), 401 (M^+^-Me), 398 (M^+^-H~2~O), 384 (M^+^-MeOH ,100 %), 353, 275, 210, 43; δ~H~ (CDCl~3~): 0.69 (s, 3H, 18-CH~3~), 1.25 ((s, 3H, 19-CH~3~), 3.18 (m, 1H, 3-CH), 3.35 (s, 3H, 3-OCH~3~), 3.88 (m, 1H, 7-H), 5.35 (t, 1H, 6-H with 7β-ol), 5.70 (d, 1H, 6-H with 7α-ol).

### (5) DCA-sensitized photooxygenation of **2**

Compound **2** (80 mg) in MeCN solution containing DCA (150 mL ; 4×10^-4^ mol dm^-3^) was irradiated for 8 h with oxygen bubbling, then a similar work-up and isolation procedure as in (1) were employed. The following three purified compounds were obtained: **2** (12 mg, recovered), **2a** (28.2 mg) and **2b** (39.2 mg).

### (6) DCA-sensitized photooxygenation of **3**

Compound **3** (88.8 mg) in MeCN solution containing DCA (100 mL; 4×10^-4^ mol dm^-3^) was irradiated for 7 h with oxygen bubbling, then a similar work-up and isolation procedure as in(1) were employed. The following three purified compounds were obtained: **3** (13.6 mg, recovered); 3β- acetyloxycholest-6-en-5α-ol (**3a**) (46.8 mg); ν~max~: 3507, 3451 (b, OH), 2945, 2868, 1728 (s, C=O), 1672 (w, C=C), 1458, 1377, 1243 cm^-1^; m/e: 443 (M^+^-1), 426 ((M^+^-H~2~O), 411 (M^+^-H~2~O-CH~3~), 382, 367 (100 %), 351; δ~H~ (CDCl~3~): 0.68 (s, 3H, 18-CH~3~), 1.26 (s, 3H, 19-CH~3~), 2.04 (s, 3H, 3-CH~3~COO), 2.37 (m, 1H), 4.98 (m, 1H, 3-CH), 5.62 (s, 2H, 6- and 7-H); 3β-acetyloxy-cholest-5-en-7(α,β)-ol (**3b**) (22.3 mg); ν~max~: 3479 (b, OH), 2945, 2868, 1735 (s, C=O), 1672 (w, C=C), 1451, 1370, 1032 cm^-1^; m/e: 443 (M^+^-1), 426 (M^+^-H~2~O), 411, 399, 383, 367, 351, 174, 57, 43; δ~H~ (CDCl~3~): 0.68 (s, 3H, 18-CH~3~), 1.26 (s, 3H, 19-CH~3~), 2.04 (s, 3H, 3-CH~3~COO), 2.54 (m, 1H), 3.89 (m, 1H, 7-CH), 4.76 (s, 1H, 3-CH), 5.35 (s, 1H, 6-H with 7β-ol), 5.72 (s, 1H, 6-H with 7α-ol).

### (7) LF-sensitized photooxygenation of **3** in MeCN

Compound **3** (86.7 mg) in an MeCN solution containing LF (100 mL; 5×10^-4^ mol dm^-3^) was irradiated for 12 h with oxygen bubbling, then a work-up and isolation procedure similar to those described in (1) were employed. The following three purified compounds were obtained: recovered **3** (22.5 mg), **3a** (42.2 mg) and **3b** (18 mg).

### (8) DCA-sensitized photooxygenation of **4**

Compound **4** (80 mg) in MeCN solution containing DCA (100 mL; 4×10^-4^ mol dm^-3^) was irradiated for 5 h with oxygen bubbling, then a similar work-up and isolation procedure as in (1) were employed. The following three purified compounds were obtained: recovered compound **4** (42.3 mg); pseudocholest-3-en-5α-7β-diol (**4a**) (21 mg); ν~max~: 3382 (b, OH), 2931, 2840 (s, C-H), 1637 (w, C=C), 1454 cm^-1^; m/e: 384 ((M^+^-H~2~O, 24 %), 369 (M^+^-H~2~O-CH~3~, 100 %), 351 (M^+^-2H~2~O-CH~3~), 233, 135 (100 %); δ~H~ (CDCl~3~): 0.75 (s, 3H, 18-CH~3~), 1.22 (s, 3H, 19-CH~3~), 4.09 (m, 1H, 7-CH), 5.74 (m, 2H, 3-,4-H); Pseudocholest-4-en-3 (α,β)-7β-diol (**4b**) (5.2 mg); ν~max~: 3353 (b, OH), 2938, 2850 (s, C-H), 1645 (w, C=C), 1454 cm^-1^; m/e: 402 (M^+^), 384 (M^+^-H~2~O,100 %), 369 (M^+^-H~2~O-CH~3~), 351 (M^+^-2H~2~O-CH~3~), 247, 135; δ~H~ (CDCl~3~): 0.72 (s, 3H, 18-CH~3~), 1.22 (s, 3H, 19-CH~3~), 3.54 (m, 1H, 7-CH), 3.80 (m, 1H, 3-CH), 5.35 (s, 1H, 4-H with 3β-ol), 5.78 (d, 1H, 4-H with 3α-ol).

### (9) DCA-sensitized photooxygenation of **5**

Compound **5** (80 mg) in MeCN solution containing DCA (100 mL; 4×10^-4^ mol dm^-3^) was irradiated for 7 h with oxygen bubbling, then a similar work-up and isolation gave three compounds: recovered **5** (40.5 mg); 7β-methoxy-pseudocholest-3-en-5α-diol (**5a**) (21.7 mg); ν~max~: 3410 (b, OH), 2942, 2870, 1662 (w, C=C), 1382 cm^-1^; m/e: 401 (M^+^-Me), 398 (M^+^-H~2~O, 100 %), 384 (M^+^-MeOH), 366, 351; δ~H~ (CDCl~3~): 0.72 (s, 3H, 18-CH~3~), 1.21 (s, 3H, 19-CH~3~), 3.36 (s, 3H, 7-OCH~3~), 3.74 (m, 1H, 7-CH), 5.64 (m, 2H, 3-, 4-H); 7β-methoxy-pseudocholest-4-en-3 (α,β)-ol (**5b**) (6.8 mg); ν~max~: 3410 (b, OH), 2935, 2868 (s, C-H), 1670 (w, C=C), 1380 cm^-1^; m/e: 416 (M^+^), 401 (M^+^-Me), 398( (M^+^-H~2~O), 384 (M^+^- MeOH, 100 %), 366, 351; δ~H~ (CDCl~3~): 0.73 (s, 3H, 18-CH~3~), 1.21 (s, 3H, 19-CH~3~), 3.20 (m, 1H, 7- CH), 3.37 (s, 3H, 7-OCH~3~), 3.84 (m, 1H, 7-CH), 5.30 (s, 1H, 4-H with 3β-ol), 5.65 (d, 1H, 4-H with 3α-ol).
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